RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+17.9%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.07B
AUM Growth
+$1.07B
(+25%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
11.81%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
121
New
28
Increased
49
Reduced
15
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$26.4M |
| 2 |
Bausch Health
BHC
|
$18.2M |
| 3 |
Travere Therapeutics
TVTX
|
$16.8M |
| 4 |
Eli Lilly
LLY
|
$16.7M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$16.5M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
Merck
MRK
|
$25.6M |
| 3 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 4 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$18.6M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$10.3M |
Sector Composition
| 1 | Healthcare | 75.22% |
| 2 | Financials | 1.56% |
| 3 | Industrials | 0.97% |
| 4 | Technology | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$13.5B
| $14.9M | 1.39% |
375,000
+15,000
| +4% | +$596K |
|
27
Thermo Fisher Scientific
TMO
$183B
| $13.4M | 1.26% |
+100,000
| New | +$13.4M |
|
|
OREX
28
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $12.1M | 1.14% |
155,000
-13,500
| -8% | -$1.06M |
|
|
TSRO
29
DELISTED
TESARO, Inc.
TSRO
| $12.1M | 1.13% |
210,000
+22,500
| +12% | +$1.29M |
|
30
Intuitive Surgical
ISRG
$158B
| $11.4M | 1.06% |
202,500
+36,000
| +22% | +$2.02M |
|
|
INOV
31
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $11.3M | 1.06% |
+375,000
| New | +$11.3M |
|
|
RCPT
32
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $10.7M | 1% |
65,000
| – | – |
|
33
Incyte
INCY
$17B
| $10.4M | 0.97% |
113,000
| – | – |
|
|
SRCL
34
DELISTED
Stericycle Inc
SRCL
| $10.3M | 0.97% |
73,500
+23,500
| +47% | +$3.3M |
|
|
ICPT
35
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $10.2M | 0.95% |
36,000
+19,600
| +120% | +$5.53M |
|
36
Cooper Companies
COO
$13.3B
| $10.1M | 0.95% |
216,000
| – | – |
|
37
Encompass Health
EHC
$12.5B
| $9.76M | 0.91% |
+276,540
| New | +$9.76M |
|
38
Labcorp
LH
$22.8B
| $9.46M | 0.88% |
+87,300
| New | +$9.46M |
|
|
HTWR
39
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $9.22M | 0.86% |
105,000
-15,000
| -13% | -$1.32M |
|
|
SRGA
40
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $9.19M | 0.86% |
62,000
| – | – |
|
41
Prothena Corp
PRTA
$452M
| $9.06M | 0.85% |
237,500
+35,000
| +17% | +$1.33M |
|
42
Danaher
DHR
$143B
| $8.96M | 0.84% |
156,966
| – | – |
|
|
MDCO
43
DELISTED
Medicines Co
MDCO
| $8.41M | 0.79% |
300,000
+53,700
| +22% | +$1.5M |
|
|
AVDL
44
Avadel Pharmaceuticals
AVDL
$1.42B
| $8.27M | 0.77% |
460,000
-215,000
| -32% | -$3.87M |
|
|
PRAH
45
DELISTED
PRA Health Sciences, Inc.
PRAH
| $8.22M | 0.77% |
285,000
| – | – |
|
46
Vertex Pharmaceuticals
VRTX
$102B
| $8.02M | 0.75% |
68,000
+5,000
| +8% | +$590K |
|
47
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $7.98M | 0.75% |
110,000
-30,000
| -21% | -$2.18M |
|
48
Perrigo
PRGO
$3.21B
| $7.78M | 0.73% |
47,000
+4,500
| +11% | +$745K |
|
|
NVDQ
49
DELISTED
Novadaq Technologies Inc.
NVDQ
| $7.71M | 0.72% |
475,000
+97,500
| +26% | +$1.58M |
|
50
Insmed
INSM
$30.3B
| $7.59M | 0.71% |
+365,000
| New | +$7.59M |
|